Prevention of influenza in the general population

Langley, Joanne M.; Faughnan, Marie E.
November 2004
CMAJ: Canadian Medical Association Journal;11/9/2004, Vol. 171 Issue 10, p1213
Academic Journal
Background: Although all jurisdictions in Canada offer annual influenza immunization to people at high risk of complications, only Ontario has provided universal annual immunization of healthy adults and children. Use of chemotherapy (amantidine, neuraminidase inhibitors) to prevent influenza varies among provinces. We sought to systematically review the evidence for the prevention of influenza infection in the general population. Methods: The interventions reviewed were influenza vaccination and prophylactic use of neuraminidase inhibitors. The health outcomes of interest were rates of laboratory-confirmed influenza infection, clinical definitions of influenza-like illness and work absenteeism. MEDLINE and Cochrane databases were searched for relevant articles published between 1966 and March 2003. Only randomized controlled trials (RCTs) were selected. Evidence was appraised using the methodology of the Canadian Task Force on Preventive Health Care. Results: Eighteen trials involving more than 33 000 healthy adults were identified that met the inclusion criteria; of these, 15 showed that influenza vaccination with either live-attenuated and inactivated vaccines was efficacious. Eleven trials were considered to be of "good" quality, and 7 were considered to be of "fair" quality. The relative risk reduction (RRR) associated with influenza immunization in adults ranged from 0% to 91%. Fifteen RCTs involving more than 45 000 healthy children aged 6 months to 19 years were identified, of which 9 were considered to contain "good" evidence and 6 "fair" evidence. Results from 12 of these trials showed protection against influenza. The RRR ranged from 0% to 93%. There were 6 RCTs of "good" quality showing that neuraminidase inhibitors are effective in preventing influenza infection. Side effects from both influenza vaccination and neuraminidase inhibitor administration were mild. Interpretation: There are numerous RCTs of good quality in large populations that...


Related Articles

  • Flu vaccinations now underway.  // Kai Tiaki Nursing New Zealand;Apr2015, Vol. 21 Issue 3, p9 

    No abstract available.

  • Rebuttal.  // CMAJ: Canadian Medical Association Journal;1/09/2001, Vol. 164 Issue 1, p40 

    Addresses an argument made against universal influenza vaccinations which was made in the January 9, 2001 issue of the 'Canadian Medical Association Journal.' Reasons for supporting universal immunization; View that population immunization is an outstanding public health achievement; Opinion...

  • Preparing for the flu season.  // CMAJ: Canadian Medical Association Journal;10/20/98, Vol. 159 Issue 8, p981 

    Presents information from the `Statement on influenza vaccination for the 1998-1999 season,' by Canada's National Advisory Committee on Immunization. The recommended trivalent vaccine; The three high risk groups; Possible side effects. INSET: Identifying groups at high risk for...

  • WSCA offering flu shots Friday.  // Lakelander (Whitney, TX);10/25/2006, Vol. 20 Issue 43, p11 

    The article reports on the seasonal flu vaccinations that will be provided by WestShore Civic Association (WSCA) on October 27, 2006 at Laguna Park in Texas. Residents can received shots at the facility of WSCA from 12 pm to 6:30 pm. Melvin Musgrove Medicine will administer the vaccinations and...

  • Introduction of Haemophilus Influenzae type b (Hib) as pentavalent (DPT-HepB-Hib) vaccine in two states of India. Gupta, Satish; Sosler, Stephen; Lahariya, Chandrakant // Indian Pediatrics;Sep2012, Vol. 49 Issue 9, p707 

    The article offers information on Haemophilus influenza type b (Hib) vaccine in India. Hib disease contributes four percent of all annual deaths in India. In June 2011, Hib vaccine was introduced in the national immunization program of various countries. A description of the strategy used and...

  • Influvac Sub-unit.  // Royal Society of Medicine: Medicines;2002, p304 

    The article presents information on Influvac Sub-unit, a proprietary, prescription-only preparation of influenza vaccine. Influvac Sub-unit can be used as immunization for the prevention of influenza, and is available in a form of injection.

  • Flu jabs halve mortality.  // GP: General Practitioner;10/5/2007, p66 

    The article reports on a research, which has stated that vaccinating the elderly against flu can almost halve the risk of death. It was based on data collected from 18 cohort studies carried out between 1990-2000 by researchers in the U.S. Influenza vaccination was found to reduce the risk of...

  • U.S. health officials urge universal flu shots.  // MLO: Medical Laboratory Observer;Nov2005, Vol. 37 Issue 11, p8 

    The article reports that United States health officials are urging the public to get a flu shot. The rationale behind the campaign comes from the herd community concept, which says that fewer flu viruses will circulate if more people are vaccinated.

  • Influenza vaccine: basis for expanded pharmacy-based immunization services. Hayney, Mary S. // Journal of the American Pharmacists Association: JAPhA;May/Jun2004, Vol. 44 Issue 3, p411 

    Discusses the recent developments in immunization practices with an emphasis on vaccine supplies and availability of influenza vaccine. Reason behind the shortages of vaccines in some U.S. states; Information on vaccine supply in the U.S.; Vaccine demand in the country.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics